Exemestane is an aromatase inhibitor widely used for the treatment of postmenopausal breast cancer patients. Several precursors are used for its synthesis; however the final step is C-1(2) dehydrogenation of the resultant steroid to yield exemestane. A sequence of hazardous chemical reactions is ...
Evaluation of factors related to late recurrence--later than 10 years after the initial treatment--in primary breast cancer. Background: Breast cancer is associated with a relatively good prognosis. Prognostic factors examined to date are related to early recurrence while those r... R Ni...
Classification of anticancer drugs--a new system based on therapeutic targets, Cancer Treat. Rev. 29: 515- 523Espinosa, E., Zamora, P., Feliu, J.,... Enrique,Espinosa,and,... - 《Cancer Treatment Reviews》 被引量: 112发表: 2003年 Classification of anticancer drugs—a new system based...